Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults

Venous thromboembolism - apixaban (hip and knee surgery): review decision March 2015 information  

Venous thromboembolism - apixaban (hip and knee surgery): appendix A - RPP decision paper March 2015 ^{PDF 127.53 KB} 18 March 2015  

Venous thromboembolism - apixaban (hip and knee surgery): review proposal information  

Venous thromboembolism - apixaban (hip and knee surgery): appendix A - matrix of stakeholders ^{PDF 97.62 KB} 02 February 2015  

Venous thromboembolism - apixaban (hip and knee surgery): appendix B - GE proposal paper January 2015 ^{PDF 207.84 KB} 02 February 2015  

Venous thromboembolism - apixaban (hip and knee surgery): equality impact assessment - guidance development ^{PDF 75.98 KB} 25 January 2012  

Venous thromboembolism - apixaban (hip and knee surgery): final appraisal determination information  

Venous thromboembolism - apixaban (hip and knee surgery): final appraisal determination document ^{PDF 226.74 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): evaluation report  

Venous thromboembolism - apixaban (hip and knee surgery): pre-meeting briefing ^{PDF 531.59 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): Evidence Review Group report ^{PDF 1.41 MB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): Evidence Review Group report - factual accuracy check ^{PDF 131.16 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): Bristol-Myers Squibb and Pfizer ^{PDF 1.1 MB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): clarifcation  

Venous thromboembolism - apixaban (hip and knee surgery): NICE clarification letter ^{PDF 99.04 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): manufacturer response to NICE clarification letter ^{PDF 1.61 MB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): patient group, professional group and NHS organisation submission statements  

Venous thromboembolism - apixaban (hip and knee surgery): NHS Warwickshire ^{PDF 67.63 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): Royal College of Anaesthetists ^{PDF 56.57 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): expert written personal statements  

Venous thromboembolism - apixaban (hip and knee surgery): Dr Raza Alikhan ^{PDF 74.75 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): Annya Stephens-Boal ^{PDF 107.83 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): AntiCoagulation Europe (ACE) ^{PDF 91.21 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): British Orthopaedic Association ^{PDF 142.61 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): final scope ^{PDF 39.4 KB} 25 February 2011  

Venous thromboembolism - apixaban (hip and knee surgery): final matrix ^{PDF 54.74 KB} 25 November 2011  

Venous thromboembolism - apixaban (hip and knee surgery): institute's response to consultee and commentator comments on the draft scope ^{PDF 124.46 KB} 25 February 2011  

Venous thromboembolism - apixaban (hip and knee surgery): institute's response to consultee and commentator comments on the provisional matrix ^{PDF 16.46 KB} 25 February 2011  

Venous thromboembolism - apixaban (hip and knee surgery): quality impact assessment - scoping ^{PDF 48.16 KB} 25 February 2011  

Venous thromboembolism - apixaban (hip and knee surgery): draft scope for consultation (pre-referral) - September 2009 ^{PDF 32.85 KB} 02 February 2010  

Venous thromboembolism - apixaban (hip and knee surgery): provisional matrix (pre-referral) - September 2009 ^{PDF 31.33 KB} 02 February 2010